ACC: Rivaroxaban Beats Aspirin for Lower Risk of Recurrent VTE
Low dose cuts risk in equipoise for continued anticoagulation; rate of bleeding similar to aspirin
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.